These candidate targets of miR-211 are: ATP2B1, CDH2, GLIS3, KCNMA1, MEIS2, NCAM-1, NF-AT5, PRPF38B, and TCF12. Of these, the following seven genes were previously implicated in cancer progression: ATP2B [45], CDH2[19], [46], [47], GLIS3[48], KCNMA1[49]–[51], MEIS2[52], [53], NCAM-1 [[54], and NF-AT5[55]. This evidence concerns the gene MEIS2 and cancer.